Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation

NCT04837339 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT04837339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04837339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
Lead sponsor
Hopital Foch
Phase
Not applicable
Overall status
Recruiting
Start date
March 17, 2022
Completion date
March 31, 2037
Enrollment
900 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant failure, lung transplant failure and rejection, lung transplant rejection, lung transplant; complications